Psychological — Examining the Attitudes of Physiotherapists on Patient Psychology
Citation(s)
da Silva TM, Costa Lda C, Garcia AN, Costa LO What do physical therapists think about evidence-based practice? A systematic review. Man Ther. 2015 Jun;20(3):388-401. doi: 10.1016/j.math.2014.10.009. Epub 2014 Oct 24.
Lancelott-Redfern C, Quinlan K A physiotherapist's life. Br Dent J. 2014 Jun 13;216(11):610-1. doi: 10.1038/sj.bdj.2014.464. No abstract available.
Lonsdale C, Hall AM, Williams GC, McDonough SM, Ntoumanis N, Murray A, Hurley DA Communication style and exercise compliance in physiotherapy (CONNECT): a cluster randomized controlled trial to test a theory-based intervention to increase chronic low back pain patients' adherence to physiotherapists' recommendations: study rationale, design, and methods. BMC Musculoskelet Disord. 2012 Jun 15;13:104. doi: 10.1186/1471-2474-13-104.
Nicholls DA, Gibson BE Physiotherapy as a complex assemblage of concepts, ideas and practices. Physiother Theory Pract. 2012 Aug;28(6):418-9. doi: 10.3109/09593985.2012.692557. No abstract available.
Examining the Attitudes of Physiotherapists on Patient Psychology: the Use of Psychology Methods and Psychology Education.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
